• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [1476 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2002 Medical Services Advisory Committee (MSAC) Neonatal hearing screening
2002 Adelaide Health Technology Assessment (AHTA) Antenatal screening for heritable thrombophilia
2002 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Maternal screening for fetal abnormality
2002 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Screening for chlamydia with hometest]
2001 NIHR Health Technology Assessment programme An assessment of screening strategies for fragile X syndrome in the UK
2001 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Fragile X syndrome: the role of molecular diagnosis and screening in an integrated approach to services
2001 Health Council of the Netherlands Gezondheidsraad (GR) Screening for colorectal cancer. Review, expert consultation
2001 Health Council of the Netherlands Gezondheidsraad (GR) Prenatal screening: Down syndrome, neural tube defects, routine ultrasound. Systematic review, expert panel
2001 The Swedish Council on Health Technology Assessment (SBU) Human papillomavirus testing in primary cervical cancer screening - early assessment briefs (ALERT)
2001 The Swedish Council on Health Technology Assessment (SBU) Maternal serum screening for Down syndrome - early assessment briefs (ALERT)
2001 NIHR Health Technology Assessment programme The measurement and monitoring of surgical adverse events
2001 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Osteoporosis and fractures among people aged 65 and over: recommendations for an integrated framework for action in Quebec
2001 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Cancer of the colon and rectum - diagnosis and screening]
2001 Norwegian Knowledge Centre for the Health Services (NOKC) Screening for colorectal cancer
2001 Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) Issues concerning prenatal screening and diagnosis of Down syndrome
2001 Agency for Healthcare Research and Quality (AHRQ) Telemedicine for the Medicare population. Pediatric, obstetric and clinician-indirect home interventions in telemedicine
2001 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Biochemical screening for fetal chromosomal abnormalities and neural tube defects - a technology assessment
2001 Unit of Health Economics and Technology Assessment in Health Care (HunHTA) Breast and gynaecological cancer screening in Hungary: Cost effectiveness analysis, (in: Dorossy L, Organised screening in oncology; Guidebook in quality improvement and methodology)
2001 Basque Office for Health Technology Assessment (OSTEBA) [Analysis of the appropriateness of hospital admissions from emergencies]
2001 Canadian Task Force on Preventive Health Care (CTFPHC) Screening strategies for colorectal cancer: systematic review and recommendations
2001 Canadian Task Force on Preventive Health Care (CTFPHC) Prevention of early-onset group B streptococcal (GBS) infection in the newborn: systematic review and recommendations
2001 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) PSA screening for prostate carcinoma - systematic health economic review
2001 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Use of mammography and Papanicolaou's test for the early detection of breast and uterine cervix cancer in Spain. IPE-02/34 (Public report)
2001 Institute for Clinical Systems Improvement (ICSI) Computed tomographic colongraphy for detection of colorectal polyps and neoplasms
2001 Institute for Clinical Systems Improvement (ICSI) Computed tomography screening for lung cancer
2001 Institute for Clinical Systems Improvement (ICSI) HPV DNA testing for cervical cancer
2001 Institute for Clinical Systems Improvement (ICSI) PET scans for solitary pulmonary nodules, non-small cell lung cancer, recurrent colorectal cancer, lymphoma, and recurrent melanoma
2001 Canadian Task Force on Preventive Health Care (CTFPHC) Prevention and treatment of violence against women: systematic review & recommendations.
2001 Agency for Healthcare Research and Quality (AHRQ) Screening for bacterial vaginosis in pregnancy
2001 Agency for Healthcare Research and Quality (AHRQ) Screening for chlamydial infection
2001 Agency for Healthcare Research and Quality (AHRQ) Newborn hearing screening
2001 Agency for Healthcare Research and Quality (AHRQ) Screening for lipid disorders
2001 Agency for Healthcare Research and Quality (AHRQ) Screening for skin cancer
2001 HAYES, Inc. First-trimester prenatal screening using nuchal translucency combined with maternal PAPP-A and free beta-hCG levels
2001 Hannover Medical School, Medizinische Hochschule Hannover (MHH) Biochemical screening for fetal chromosomal abnormalities and neural tube defects - a technology assessment
2000 The Swedish Council on Health Technology Assessment (SBU) Stomach pain - evidence-based methods in the diagnosis and treatment of dyspepsia
2000 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Neonatal screening for cystic fibrosis
2000 NIHR Health Technology Assessment programme Systematic review of the determinants of screening uptake and interventions for increasing uptake
2000 NIHR Health Technology Assessment programme Liquid-based cytology in cervical screening: a rapid and systematic review
2000 NIHR Health Technology Assessment programme Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views
2000 British Columbia Office of Health Technology Assessment (BCOHTA) Triple-marker screening in British Columbia: current practice, future options
2000 New Zealand Health Technology Assessment (NZHTA) Effectiveness and cost effectiveness of automated and semi-automated cervical screening devices: a systematic review of the literature
2000 Finnish Office for Health Care Technology Assessment (Finohta) [Colorectal cancer screening in Finland: conditions and effects]
2000 NIHR Health Technology Assessment programme Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis
2000 Alberta Heritage Foundation for Medical Research (AHFMR) Mammography screening: mortality rate reduction and screening interval
2000 Basque Office for Health Technology Assessment (OSTEBA) [Routine analysis requesting profiles in primary healthcare: comparison of guidelines and cost analyses in the Basque country]
2000 NIHR Health Technology Assessment programme Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research
2000 NIHR Health Technology Assessment programme False-negative results in screening programmes: systematic review of impact and implications
2000 NIHR Health Technology Assessment programme A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression
2000 NIHR Health Technology Assessment programme Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration
2000 NIHR Health Technology Assessment programme Intrathecal pumps for giving opioids in chronic pain: a systematic review
2000 NIHR Health Technology Assessment programme The management of dyspepsia: a systematic review
2000 Finnish Office for Health Care Technology Assessment (Finohta) [The effects of extending the use of mammography screening: a report on the cost-effectiveness of breast cancer screening in 60 to 69 year-old women]
2000 West Midlands Health Technology Assessment Collaboration (WMHTAC) The effectiveness of toluidine blue dye as an adjunct to oral cancer screening in general dental practice
2000 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Virtual colonoscopy in screening for colorectal cancer
2000 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Clinical evaluation of digital mammography in breast cancer diagnosis and screening
2000 NIHR Horizon Scanning Centre (NIHR HSC) Opto-electronic devices for the detection of cervical cancer - horizon scanning review
2000 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Triple test for all pregnant women? A health technology assessment]
2000 Health Technology Advisory Committee (HTAC) Helical computed tomography (CT) for lung cancer screening for asymptomatic patients
2000 Institute for Clinical Systems Improvement (ICSI) Densitometry as a diagnostic tool for the identification and treatment of osteoporosis in women
2000 Institute for Clinical Systems Improvement (ICSI) Fetal fibronectin for the prediction of preterm labor
2000 HAYES, Inc. Apolipoprotein B testing for screening, diagnosis, and management of dyslipidemia and cardiovascular disease
2000 HAYES, Inc. Apolipoprotein E testing for screening, diagnosis, and management of dyslipidemia and cardiovascular disease
2000 HAYES, Inc. CA-125 for ovarian cancer screening in normal-risk women
2000 HAYES, Inc. High-density lipoprotein subclass testing for screening, diagnosis, and management of dyslipidemia and cardiovascular disease
2000 HAYES, Inc. Homocysteine testing for screening, diagnosis, and management of dyslipidemia and cardiovascular disease
2000 HAYES, Inc. Lipoprotein(a) enzyme immunoassay for screening, diagnosis, and management of dyslipidemia and cardiovascular disease
2000 HAYES, Inc. Low density lipoprotein subclass testing for screening, diagnosis, and management of dyslipidemia and cardiovascular disease
2000 Hannover Medical School, Medizinische Hochschule Hannover (MHH) PSA screening for prostate carcinoma
2000 ECRI Automated Pap smear screening technologies: the AutoPap System
1999 New Zealand Health Technology Assessment (NZHTA) The early detection and diagnosis of breast cancer: a literature review - an update
1999 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Appropriateness of systematic screening for prostatic cancer by prostate specific antigen (PSA)
1999 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Opportunity of a screening programme for deafness in the newborn
1999 Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) Colorectal cancer screening
1999 NIHR Health Technology Assessment programme Screening for cystic fibrosis
1999 Alberta Heritage Foundation for Medical Research (AHFMR) Selective testing with bone density measurement
1999 University of York Complications of diabetes: screening for retinopathy; management of foot ulcers
1999 NIHR Health Technology Assessment programme Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis
1999 NIHR Health Technology Assessment programme A systematic review of the role of human papillomavirus testing within a cervical screening programme
1999 Basque Office for Health Technology Assessment (OSTEBA) Prostate cancer screening: evidence synthesis and update (INAHTA Joint Project)
1999 Health Council of the Netherlands Gezondheidsraad (GR) Screening for hemochromatosis
1999 Health Council of the Netherlands Gezondheidsraad (GR) Screening and treatment of adolescents with schizophrenia
1999 Norwegian Knowledge Centre for the Health Services (NOKC) Screening for prostate cancer, Norwegian review of international studies
1999 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Opportunity of a screening program for genetic hemochromatosis
1999 Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Evaluation of the PAPNET-system in cervix screening - primary research
1999 Wessex Institute for Health Research and Development (WIHRD) Reducing the interval for diabetic retinal screening
1999 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Evaluation of obstetrical ultrasound examination in the monitoring of normal pregnancy in primary health care
1999 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Diagnosis of mammary lesions detected through mammography screening. IPE-99/21 (Public report)
1999 Scottish Health Purchasing Information Centre (SHPIC) Follow-up in colo-rectal tumours
1999 Agency for Healthcare Research and Quality (AHRQ) Systematic review of the literature regarding the diagnosis of sleep apnea
1999 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Clinical and economic evaluation of screening for genetic hemochromatosis screening in France
1999 Agency for Healthcare Research and Quality (AHRQ) Evaluation of cervical cytology
1999 Hannover Medical School, Medizinische Hochschule Hannover (MHH) PSA screening for prostate carcinoma
1999 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Clinical and economic evaluation: screening for permanent hearing loss in neonates using otoacoustic emissions
1999 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Screening for congenital hypothyroidism
1999 Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Screening for diabetic retinopathy
1999 Agency for Healthcare Research and Quality (AHRQ) Diagnosis of attention-deficit/hyperactivity disorder
1998 NIHR Health Technology Assessment programme Antenatal screening for Down's syndrome: a review
1998 NIHR Health Technology Assessment programme Screening for ovarian cancer: a systematic review
1998 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Leukoreduction: the techniques used, their effectiveness and costs - nonsystematic review